Haptena Therapeutics
PrivateLast Round
Seed
Dec 16, 2025
Total Funding Raised
$3.53M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Haptena Therapeutics is a biotechnology company that develops next-generation immunotherapies for oncogene-driven cancers by integrating precision oncology and immune engineering.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Haptena Therapeutics Comparables
Compare Haptena Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adventris Pharmaceuticals | 85% | |
| Affini-T Therapeutics | 82% | |
| Aethon Therapeutics | 82% |
For institutional investors. Book with your work email.
Haptena Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 16, 2025 |
For institutional investors. Book with your work email.
Haptena Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Claris Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 16, 2025
$4M raised, led by Claris Ventures.
For institutional investors. Book with your work email.
Haptena Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Haptena Therapeutics's valuation, stock price, and market status.
Is Haptena Therapeutics a public or private company?
Haptena Therapeutics is a private company.
What is the current stock price of Haptena Therapeutics?
Haptena Therapeutics is a private company, so its shares have no public market price. Caplight tracks Haptena Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Haptena Therapeutics worth (valuation)?
Valuation information for Haptena Therapeutics is not publicly available.
Can I buy Haptena Therapeutics stock?
Haptena Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Haptena Therapeutics's last funding round?
Haptena Therapeutics's most recent funding round was Seed on December 16, 2025.
Who are the main investors in Haptena Therapeutics?
Key investors in Haptena Therapeutics include Claris Ventures.
Will Haptena Therapeutics IPO soon?
No public IPO plans have been announced for Haptena Therapeutics.
How can I track Haptena Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Haptena Therapeutics's shares on secondary markets.